SUFENTA PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
When do Sufenta Preservative Free patents expire, and when can generic versions of Sufenta Preservative Free launch?
Sufenta Preservative Free is a drug marketed by Rising and is included in one NDA.
The generic ingredient in SUFENTA PRESERVATIVE FREE is sufentanil citrate. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sufenta Preservative Free
A generic version of SUFENTA PRESERVATIVE FREE was approved as sufentanil citrate by HIKMA on December 15th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SUFENTA PRESERVATIVE FREE?
- What are the global sales for SUFENTA PRESERVATIVE FREE?
- What is Average Wholesale Price for SUFENTA PRESERVATIVE FREE?
Summary for SUFENTA PRESERVATIVE FREE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Patent Applications: | 721 |
| DailyMed Link: | SUFENTA PRESERVATIVE FREE at DailyMed |
US Patents and Regulatory Information for SUFENTA PRESERVATIVE FREE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | SUFENTA PRESERVATIVE FREE | sufentanil citrate | INJECTABLE;INJECTION | 019050-001 | May 4, 1984 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SUFENTA PRESERVATIVE FREE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Rising | SUFENTA PRESERVATIVE FREE | sufentanil citrate | INJECTABLE;INJECTION | 019050-001 | May 4, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SUFENTA PRESERVATIVE FREE
See the table below for patents covering SUFENTA PRESERVATIVE FREE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Czech Republic | 7601632 | ⤷ Sign Up | |
| Sweden | 426486 | ANALOGIFORFARANDE FOR FRAMSTELLNING AV N-(4-PIPERIDINYL)-N-FENYLAMIDER OCH -KARBAMAT | ⤷ Sign Up |
| Czech Republic | 278060 | N-(4-PIPERIDINYL)-N-PHENYL AMIDES AND CARBAMATES | ⤷ Sign Up |
| South Africa | 7601528 | ⤷ Sign Up | |
| Sweden | 7602740 | ⤷ Sign Up | |
| Bulgaria | 28259 | METHOD OF OBTAINING OF N- (4- PIPERIDINYL)- N- PHENYLAMIDS AND CARBAMITES | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SUFENTA PRESERVATIVE FREE
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2114383 | SPC/GB16/004 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: SUFENTANIL; REGISTERED: UK EU/1/15/1042 20150922 |
| 2114383 | CA 2016 00007 | Denmark | ⤷ Sign Up | PRODUCT NAME: SUFENTANIL, HERUNDER SUFENTANIL SOM CITRAT; REG. NO/DATE: EU/1/15/1042/001-006 20150922 |
| 2114383 | CR 2016 00007 | Denmark | ⤷ Sign Up | PRODUCT NAME: SUFENTANIL; REG. NO/DATE: EU/1/15/1042/001-006 20150922 |
| 2114383 | 122016000023 | Germany | ⤷ Sign Up | PRODUCT NAME: SUFENTANIL, WAHLWEISE IN FORM VON SUFENTANILCITRAT; REGISTRATION NO/DATE: EU/1/15/1042 20150918 |
| 2114383 | 300797 | Netherlands | ⤷ Sign Up | PRODUCT NAME: SUFENTANIL, DESGEWENST IN DE VORM VAN SUFENTANILCITRAAT; REGISTRATION NO/DATE: EU/1/15/1042 20150922 |
| 2114383 | 16C0010 | France | ⤷ Sign Up | PRODUCT NAME: SUFENTANIL; REGISTRATION NO/DATE: EU/1/15/1042 20150918 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
